Decarboxylase

Carboxy-lyases, also known as decarboxylases, are carbon–carbon lyases that add or remove a carboxyl group from organic compounds. These enzymes catalyze the decarboxylation of amino acids, beta-keto acids and alpha-keto acids.

Cat No.	product name
T7454	4-Bromo-3-hydroxybenzoic acid	4-bromo-3-hydroxybenzoic acid is a potent inhibitor of the enzyme histidine decarboxylase.
T6795	Carbidopa	Carbidopa is an aromatic-L-amino-acid decarboxylase inhibitor (IC50: 29±2 μM). It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA.
T0737	L-Ornithine	L-ornithine has an anti-fatigue function in facilitating the excretion of ammonia and increasing the efficiency of energy consumption.
T2148	Carbidopa monohydrate	Carbidopa Hydrate is an inhibitor of DOPA decarboxylase, preventing the conversion of levodopa to dopamine.
T2593	Eflornithine hydrochloride hydrate	Eflornithine hydrochloride is a specific, irreversible inhibitor of ornithine decarboxylase.
T17166	Tritoqualine	Tritoqualine is used as an inhibitor of histidine decarboxylase.

Cat No.

product name

T7454

4-Bromo-3-hydroxybenzoic acid

4-bromo-3-hydroxybenzoic acid is a potent inhibitor of the enzyme histidine decarboxylase.

T6795

Carbidopa

Carbidopa is an aromatic-L-amino-acid decarboxylase inhibitor (IC50: 29±2 μM). It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA.

T0737

L-Ornithine

L-ornithine has an anti-fatigue function in facilitating the excretion of ammonia and increasing the efficiency of energy consumption.

T2148

Carbidopa monohydrate

Carbidopa Hydrate is an inhibitor of DOPA decarboxylase, preventing the conversion of levodopa to dopamine.

T2593

Eflornithine hydrochloride hydrate

Eflornithine hydrochloride is a specific, irreversible inhibitor of ornithine decarboxylase.

T17166

Tritoqualine

Tritoqualine is used as an inhibitor of histidine decarboxylase.